Equity
€713,435
SELFPHARMA has made a profit in every financial year since 2009.
SELFPHARMA
Lifetime
15 annual accounts with figures on one time axispeak €357,114 (2023)
€350,855
peak €75,599 (2022)
€50,557
peak €713,435 (2025)
€713,435
€643,572
peak 6.4 FTE (2019)
-not published
Board1 name since 2008
1 director
Documentsfilings and deeds
11-10-202672 days late
2025abbreviated format
No annual accounts filed for 2024
Key points
from the 2025 annual accountsChecked score
Bankruptcy probability within 12 months
Financial strength
Score breakdown
Comparable companies, two years later
In July 2024, 10,902 companies had the same profile as SELFPHARMA has now. Each dot stands for 28 companies, two years later.
95.2%
were still trading
4.0%
stopped another way
0.7%
went bankrupt
Test of the method
The method was tested on the 497,331 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 2.9% | 3.1% |
| 10 | 5.6% | 6.1% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 10,902 companies, not a prediction for SELFPHARMA. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Recent changes
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0806621811
Reappointment: (sole director)
General meeting of 22-02-2024 · Gazette deed
Company renamed from CITYPHARMA to SELFPHARMA
General meeting of 09-12-2016 · Gazette deed
First establishment
CITYPHARMA, Baraplein 2, Anderlecht
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| SELFPHARMA Anderlecht | €1.4m | €350,855 | 52.6% | - |
| APOTHEEK MORTELMANS Heist-op-den-Berg | €1.4m | €340,265 | 67.0% | - |
| APOTHEKER STEVEN VRIJDAG Dendermonde | €1.3m | €326,784 | 47.0% | 0.9 |
| PEP PHARMA Pepinster | €1.3m | €326,063 | 36.4% | 1.6 |
| PHARMACIE DU GROS FAYT Courcelles | €1.2m | €340,808 | 61.9% | 2 |
| PHARMACIE DE LA VESDRE Verviers | €1.4m | €302,084 | 42.2% | - |
| DE LA DREVE Waterloo | €1.4m | €312,374 | 25.9% | 2.6 |
These companies have the same main activity as SELFPHARMA: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €1.2m and €1.4m, founded between 2007 and 2010.
Official details
Source: KBO- Status
- Active since 26-09-2008Normal situation
- Activity
- Retail sale of pharmaceutical productsNACE 47730
- Establishment unit
- 2.173.692.3011070 Anderlecht, since 01-10-2008
- Financial year end
- 31 December
- Peppol
- Reachable since 13-10-2025
Annual accounts 2025
- ≈ €1.3mestimated
- €1.4m
- Employeeson 31-12-2025
- 5
- Filing
- Filed on 11-10-2026
Insights on SELFPHARMA
SELFPHARMA files the abbreviated format. That format states no turnover. The gross margin rose from €186,937 in 2009 to €350,855 in 2025.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about SELFPHARMA
- What is the company number of SELFPHARMA?
- The company number of SELFPHARMA is 0806.621.811. The VAT number is the same number with BE in front: BE 0806.621.811.
- Where is SELFPHARMA based?
- The registered office is at Baraplein 2, 1070 Anderlecht.Company details
- What does SELFPHARMA do?
- According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
- What is the legal form of SELFPHARMA?
- SELFPHARMA is a private limited company (BV).
- When was SELFPHARMA founded?
- SELFPHARMA was founded on 26-09-2008.
- Is SELFPHARMA still active?
- Yes, SELFPHARMA is an active enterprise in the KBO register.
- How many employees does SELFPHARMA have?
- SELFPHARMA had an average of 4.6 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
- What is the turnover of SELFPHARMA?
- The turnover in financial year 2025 is ≈ €1.3m. This figure is estimated from the gross margin of €350,855 and 47 comparable companies (NACE 477). It probably lies between €950,000 and €2.0m.
- Is SELFPHARMA profitable?
- In financial year 2025, SELFPHARMA made a profit of €50,557.
- Where can I find the annual accounts of SELFPHARMA?
- SELFPHARMA filed 15 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of SELFPHARMA due?
- SELFPHARMA must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed
See how customers, suppliers and banks see your own company and what to improve first.